Invitae Appoints Kimber Lockhart to its Board of Directors
Invitae Corporation (NYSE: NVTA) announced the appointment of Kimber Lockhart to its Board of Directors, effective September 10, 2020. Lockhart brings extensive experience in technology and product development, having previously served as CTO at One Medical and held various engineering roles at Box. CEO Sean George emphasizes that her expertise in scaling fast-growth businesses will be crucial for Invitae's mission to integrate genetic information into mainstream healthcare. Lockhart expressed enthusiasm about joining Invitae during a pivotal growth phase.
- Appointment of Kimber Lockhart expected to enhance strategic growth and technology integration.
- Lockhart's experience in scaling technology platforms can provide valuable insights for Invitae.
- Potential gaps in continuity as new board members might take time to adapt to company culture.
SAN FRANCISCO, Sept. 11, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Kimber Lockhart to its Board of Directors, effective September 10, 2020.
"We are excited to welcome Kimber Lockhart to our board of directors, bringing expertise in scaling fast-growth businesses that will provide valuable insight as we continue to grow," said Sean George, co-founder and chief executive officer of Invitae. "Her expertise as a product, engineering and infrastructure leader, combined with her perspective on leveraging technology to improve healthcare for patients, will be a valuable addition to our board as we continue to pursue our mission to bring genetics to mainstream medicine to improve healthcare for billions of people around the world."
"I'm happy to join the board of directors at Invitae at this exciting time in the company's continued growth," said Lockhart. "Invitae's approach is unique and the company's capabilities combined with its dedication to its mission to make comprehensive genetic information services widely available has the potential to transform healthcare for patients worldwide."
Lockhart is an experienced technology leader, scaling technology platforms to support rapid business growth. Since 2015, Lockhart has served as chief technology officer at One Medical, a national leader in technology-enabled primary care, where she was previously vice president of engineering from 2014 to 2015. Prior to joining One Medical, Lockhart served in various engineering leadership roles at online file-sharing service Box from 2009 to 2014. Previously, Lockhart was co-founder and CEO of Increo Solutions, provider of document rendering and collaboration technologies, which was acquired by Box in 2009. She holds a B.S. in Computer Science from Stanford University.
About Invitae
Invitae Corporation (NYSE: NVTA) is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company's website at invitae.com.
Contact:
Laura D'Angelo
ir@invitae.com
(628) 213-3369
View original content to download multimedia:http://www.prnewswire.com/news-releases/invitae-appoints-kimber-lockhart-to-its-board-of-directors-301128086.html
SOURCE Invitae Corporation
FAQ
Who is Kimber Lockhart and what role has she been appointed to at Invitae?
What is the significance of Kimber Lockhart's appointment for Invitae (NVTA)?
When did Kimber Lockhart join Invitae's Board of Directors?
What experience does Kimber Lockhart bring to Invitae?
